Back

Biophysical parameters of pulmonary vein isolation with very high-power short-duration compared to conventional radiofrequency ablation guided by ablation index

11 May 2024 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation 1 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speakers

Photo
Doctor Fabiana Duarte

Hospital Divino Espirito Santo, Ponta Delgada (Portugal)

Photo
Doctor Rafael Teixeira

Unidade local de Saude Gaia/Espinho EPE, Vila Nova de Gaia (Portugal)

5 More presentations in this session

Presentation thumbnail
Gender differences in atrial cardiomyopathy: insights from patients with atrial fibrillation
Doctor R. Teixeira (Vila Nova de Gaia, PT)
Abstract Slides Video
Presentation thumbnail
Role of combined pulmonary vein isolation with left atrial ganglionated plexus ablation in paroxysmal atrial fibrillation and sinus bradycardia
Doctor S. Paula (Barreiro, PT)
Abstract Slides Video
Presentation thumbnail
Effects of atrial fibrillation ablation in patients with heart failure: a systematic review and meta-analysis
Doctor A. Buongiorno (Genoa, IT)
Abstract Slides Video
Presentation thumbnail
Cost-effectiveness of AF ablation versus medical therapy for the treatment of atrial fibrillation and heart failure.
Professor M. Gallagher (London, GB)
Abstract Slides Video
Presentation thumbnail
Association of elevated LV filling pressure and development of LV systolic dysfunction in lone atrial fibrillation
Professor S. Ryu (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation 1

The Event

Event poster

Heart Failure 2024

11 May 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Procedural and clinical outcomes of very high-power short-duration versus ablation index-guided pulmonary vein isolation -The Q-POWER Study -
thumbnail
Congress Presentation
The procedural characteristics of radiofrequency ablation points in patients undergoing atrial fibrillation ablation: comparison between standard vs very high-power short-duration.
thumbnail
Congress Presentation
Efficiency, efficacy and safety of very high-power short-duration radiofrequency atrial fibrillation ablation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources